Ligand profile
ADI
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32224 — DNA polymerase IV
Identifiers
Database identifiers and provenance.
- Ligand ID
ADI- PDB
3gv5- UniProt (similar protein)
Q9UNA4- Target protein
- KP13_32224
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 192.1
- −1 ≤ LogP ≤ 5 0.31
- MW ≤ 500 Da 395.2
- LogP ≤ 5 0.31
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 192.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO[P@@](=O)(O)OP(=O)(O)O)Nc1nc(c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO[P@@](=O)(O)OP(=O)(O)O)N
InChI=1S/C10H15N5O8P2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(22-7)3-21-25(19,20)23-24(16,17)18/h4-7H,1-3H2,(H,19,20)(H2,11,12,13)(H2,16,17,18)/t6-,7+/m0/s1InChI=1S/C10H15N5O8P2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(22-7)3-21-25(19,20)23-24(16,17)18/h4-7H,1-3H2,(H,19,20)(H2,11,12,13)(H2,16,17,18)/t6-,7+/m0/s1
QYFSANXOEHYVFG-NKWVEPMBSA-NQYFSANXOEHYVFG-NKWVEPMBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00817
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ADI →
- PDB RCSB structure 3gv5 →
- UniProt UniProt Q9UNA4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ADI”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32224.
PDB 31
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).